Medical - Regent Systems

Synermed is a world leader in the development of Liquid Stable and Near-infrared Diagnostic reagents for use in Clinical Chemistry Laboratories. This reagent technology is in routine use in hospitals throughout Europe solving problems on a wide variety of analyser systems.

Synermed is the world’s leading developer of quality analytical methods in clinical chemistry. The company's design focus is in areas of traditional weakness of conventional chemistries, namely the elimination of common interferences and the stabilisation of enzymes in liquid reagents.

As has been highlighted by the work of Glick and others, almost all conventional procedures for routinely
automated chemistries exhibit substantial residual interferences in samples compromised by haemolysis,
icterus or turbidity. All of the consequences of these interferences are unwelcome, from specimen rejection,
to special handling, repeat testing and misleading clinical information. Ultimately, in a field which is constantly pressured to contain cost, laboratories pay a disproportionate surcharge to process a minority of specimens,
on which the results are still flawed.

Synermed has developed a generic approach to the elimination of these problems, using classical reactions adapted to be read in the near infrared spectrum, at wavelengths where the interferents are transparent.
The technology has been through a five-year, world-wide validation process, across the full range of routine tests, on all commonly-used analysers. The results have been exceptional. In summary, Synermed method offer the unique combination of superior accuracy, enhanced productivity, and lower operating cost.